维拉帕米尔通过激活Nrf2/HO-1通路来缓解线粒体功能障碍,减轻肌病的严重程度
Zengguang Wang1, Zhenglin Dong1, Yiming Li1
1Department of Orthopedic Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, No. 639 Zhi Zao Ju Road, Huangpu District, Shanghai 200011, China.
维拉帕米尔有效地通过减少炎症和亡来治疗肌病. 它还通过Nrf2/HO-1通道改善线粒体功能,显示为肌损伤的治疗方法.
科学领域:
- 整形外科 整形外科 整形外科
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 肌病明显损害肌功能,其机制不明确,治疗选择有限.
- 目前用于肌病的药理干预往往产生低于最佳的结果.
- 维拉帕米尔是一种已知的抗炎和抗氧化药物,正在研究其治疗潜力.
研究的目的:
- 为了研究维拉帕米尔对肌病的作用.
- 阐明维拉帕米尔改善肌病的潜在机制.
- 为了评估维拉帕米尔对炎症,亡和线粒体功能在十细胞和体内模型中的影响.
主要方法:
- 试验室内:初级细胞接受了白蛋白-1β (IL-1β) 和维拉帕米尔 (5μM) 的治疗.
- 在体内:由原酶注射诱导的老鼠阿基勒斯肌病模型,与维拉帕米尔 (5微米) 管理.
- 评估了细胞外矩阵降解,细胞亡,MAPK/NFκB通路,线粒体功能和Nrf2/HO-1通路激活.
主要成果:
- 维拉帕米尔减弱了IL-1β诱导的细胞外基质降解和十细胞中的亡.
- 维拉帕米尔抑制了与炎症相关的MAPK/NFκB通路.
- 维拉帕米尔通过Nrf2/HO-1通路激活改善了线粒体功能障碍,Nrf2抑制剂ML385.5阻止了这种效应.
结论:
- 维拉帕米尔在体外和体外模型中减轻了肌病症的严重程度.
- 治疗效果包括抑制炎症和激活Nrf2/HO-1通路.
- 维拉帕米尔显示出作为肌病的有前途治疗剂的潜力,这需要进一步的研究.
更多相关视频
07:55Subcellular Fractionation for ERK Activation Upon Mitochondrial-derived Peptide Treatment
Published on: September 25, 2017
07:17Improving the Accuracy of Flow Cytometric Assessment of Mitochondrial Membrane Potential in Hematopoietic Stem and Progenitor Cells Through the Inhibition of Efflux Pumps
Published on: July 30, 2019
相关概念视频
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Mitochondrial Membranes
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
